• 1
    Jensen KME, Jørgensen JB, Mogensen P. Urodynamics in prostatism. Scand J Urol Nephrol 1988; 22: 10917
  • 2
    Chancellor MB, Blaivas JG, Kaplan SA, Axelrod S. Bladder outlet obstruction versus impaired detrusor contractility. the role of uroflow. J Urol 1991; 145: 8102
  • 3
    McConnell JD, Barry MJ, Bruskewitz RC. Benign Prostatic Hyperplasia. Diagnosis and Treatment. Agency for Health Care Policy and Research. Clinical Practice Guideline -Quick Reference Guide for Clinicians. AHCPR Publication, 94–0582 1994; 8: 117
  • 4
    Schäfer W, Nopponey R, Rubben H et al. The value of free flow rate and pressure flow-studies in the routine investigation of BPH patients. Neurourol Urodyn 1988; 7: 219
  • 5
    Rollema HJ, Van Mastrigt R. Improved indication and follow up in transurethral resection of the prostate using the computer program CLIM. A prospective study. J Urol 1992; 148: 1116
  • 6
    Golomb J, Lindner A, Siegel Y, Korczak D. Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal Controls. J Urol 1992; 147: 10447
  • 7
    Grino PB, Bruskewitz R, Blavias JG et al. Maximum urinary flow rate by uroflowmetry. automatic of visual interpretation. J Urol 1993; 149: 33941
  • 8
    Van de Beek C, Stoevelaar HJ, McDonnell J, Nijs HG, Casparie AF, Janknegt RA. Interpretation of uroflowmetry curves by urologists. J Urol 1996; 157: 1648
  • 9
    Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology 1994; 44: 1535
  • 10
    McConnell JD. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia. Urology 1994; 44: 1568
  • 11
    Poulsen AL, Schou J, Puggaard L, Torp-Pedersen S, Nordling J. Prostatic enlargement, symptomatology and pressure/flow evaluation: Interrelations in patients with symptomatic BPH. Scand J Urol Nephrol 1994; 157: 6773
  • 12
    Madsen FA, Rhodes PR, Bruskewitz RC. Reproducibility of pressure-flow variables in patients with symptomatic benign prostatic hyperplasia. Urology 1995; 46: 81620